In the latest close session, ATI (ATI) was down 1.96% at $121.72. The stock trailed the S&P 500, which registered a daily loss of 0.01%. On the other hand, the Dow registered a gain of 0.03%, and the ...

ATI-2138 Outperforms Ritlecitinib in Reversal Model of Alopecia Universalis, the Most Severe AA Phenotype -WAYNE, Pa., (GLOBE ...

ATI stock at a glance after recent performance ATI (ATI) has drawn fresh attention after a recent mix of short term pullback ...

ATI Inc. gets a Strong Buy and $139.78 target on aerospace/defense growth, 15% EBITDA CAGR, rising FCF and lower leverage.

Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that it has ...

In the latest trading session, ATI (ATI) closed at $123.11, marking a -1.25% move from the previous day. This change lagged ...

The latest trading day saw ATI (ATI) settling at $125.39, representing a +1.74% change from its previous close.

For 25 years, one name was synonymous with computer graphics. Through its trials and tribulations, it fought against other long-standing companies as well as hot new upstarts. Its most successful ...